BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

Researchers have shed new light on how a type of heart valve disease -- aortic valve stenosis -- progresses differently in males and females.

Mechanical heart valves have improved long-term survival benefit over biological valves for patients aged 50-70 years, new ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

may occur due to damage to the aortic valve leaflets or as a result of dilation of the aortic annulus. As the disease progresses, symptoms of heart failure eventually occur. The definitive ...

Olive Hospital has achieved a major breakthrough in the field of Interventional Cardiology by successfully completing its ...

MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV).

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...

For conditions such as truncus arteriosus and severe aortic stenosis without good function, infants not only need new heart valves and arteries to survive, but the new tissue also needs to grow ...

The most promising innovation in heart valve disease treatment is 'Transcatheter Aortic Valve Implantation ... procedure and predictive analytics in real-time during monitoring.